Tuesday, 23 July 2013

Personalized Medicine and Companion Diagnostic Market Q2 2013

ResearchMoz.us include new market research report "Personalized Medicine and Companion Diagnostic Market Q2 2013 - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment" to its huge collection of research reports.

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 261 tables & figures over 205 pages.

The personalized medicine (global) market is presented as follows:
  • By Company (e.g., 23andMe, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD)
  • By Geography (US, UK, EU)
  • By Segment (Targeted therapeutics, Companion Diagnostics, Esoteric tests, Esoteric lab services)
  • By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics, consumer genomics)
Who should read this report?
  • Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine
  • Industry professionals and business strategists will discover key information to propel their policies
  • Investors will gain inside information to dominant players in the industry and future forecasts
  • Scientists will get a business perspective and industry insight into how scientific breakthroughs 
Find More Reports Related to Pharmaceuticals: http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Contact Us: 
Email: sales@researchmoz.us

No comments:

Post a Comment